Sphera Funds Management Ltd. Avrobio, Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $6.91 Million - $12.7 Million	-655,874 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.79 - $17.1 $4.23 Million - $5.65 Million	330,374 Added 101.5%	655,874 $9.14 Million
Q3 2020 Nov 12, 2020	BUY	$12.99 - $19.41 $4.23 Million - $6.32 Million	325,500 New	325,500 $4.24 Million
Q4 2019 Feb 13, 2020	SELL	$13.05 - $21.88 $1.65 Million - $2.76 Million	-126,324 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $1.78 Million - $2.96 Million	126,324 New	126,324 $1.78 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.